Journal of Hepatology
Volume 51, Issue 4 , Pages 778-786 , October 2009

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

  • Luca Miele

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Selenia Vallone

      Affiliations

    • Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy
    • These authors contributed equally to this work.
    • ,
  • Consuelo Cefalo

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • These authors contributed equally to this work.
    • ,
  • Giuseppe La Torre

      Affiliations

    • Department of Experimental Medicine, Sapienza University, Rome, Italy
    • ,
  • Carmine Di Stasi

      Affiliations

    • Institute of Radiology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Fabio M. Vecchio

      Affiliations

    • Institute of Pathology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Magda D’Agostino

      Affiliations

    • Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Maria L. Gabrieli

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Vittoria Vero

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Marco Biolato

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Maurizio Pompili

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Giovanni Gasbarrini

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Gianludovico Rapaccini

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Pierluigi Amerio

      Affiliations

    • Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Clara De Simone

      Affiliations

    • Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy
    • These authors shared senior authorship.
    • ,
  • Antonio Grieco

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 30155451; fax: +39 06 35502775.
    • These authors shared senior authorship.

Received 25 March 2009 ,Revised 20 May 2009 ,Accepted 8 June 2009.

References 

  1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263–271
  2. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982–986
  3. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–835
  4. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–1741
  5. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68–73
  6. Lonardo A, Loria P, Carulli N. Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. Dig Liver Dis. 2001;33:86–87
  7. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298–304
  8. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457
  9. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3:55–78
  10. Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica. 1978;157:238–244
  11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  12. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–854
  13. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
  14. Report of the expert committee on the diagnosis and classification of diabetes mellitus diabetes care 1997; 20:1183–97.
  15. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–1725
  16. Nyfors A, Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy: two findings before and after methotrexate therapy in 88 patients. A blind study. Acta Pathol Microbiol Scand A. 1976;84:262–270
  17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  18. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–117
  19. Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2006;4:1162–1169
  20. Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 2003;48:1408–1413
  21. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum. 2003;48:3085–3095
  22. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998;25:1544–1552
  23. Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes. 2002;51:1876–1883
  24. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004;40:185–194
  25. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domı´nguez-Dı´ez A, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34:1158–1163
  26. Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol. 2008;103:1036–1042
  27. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356–1362
  28. Coulson IH, McKenzie J, Neild VS, Joseph AE, Marsden RA. A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy. Br J Dermatol. 1987;116:491–495
  29. Whiting-O’Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med. 1991;90:711–716
  30. Ryan GJ, Barry J, Bourke J, Phelan M. Methotrexate monitoring: a countrywide analysis of monitoring policies among dermatologists and rheumatologists in the republic of Ireland. Rheumatology. 2004;43:ii50
  31. Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol. 1998;38:478–485
  32. Rosenberg P, Urwitz H, Johannesson A, Ros AM, Lindholm J, Kinnman N, et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol. 2007;46:1111–1118
  33. Baker H. Psoriasis – clinical features. Br Med J. 1971;3:231–233
  34. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00442-5

doi: 10.1016/j.jhep.2009.06.008

Journal of Hepatology
Volume 51, Issue 4 , Pages 778-786 , October 2009

Article Tools

* Image Usage & Resolution